CATX•benzinga•
Perspective Therapeutics Reveals New Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET At The 2025 ASCO Annual Meeting
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 30, 2025 by benzinga